GIW XXXI ISCB-Asia V Opens Call for Papers

GIW ISCB-Asia has a rich history as a conference to present and discuss research in computational biology and computational aspects of genomics.  Both theoretical and application oriented research is welcome.

This call is for original research.  Submitted manuscripts will be peer-reviewed for oral presentation at the conference. Any co-author (registered for the conference) can present an accepted submission.  A person may be co-author of multiple submissions, but can only present one of them. 
 
We will also recommend those manuscripts for publication in one of the journals listed below.  Which journal depends on the nature and strength of the manuscript.  Authors are encouraged to let us know their preferences and may opt-out if unhappy with our recommendation.  Publication charges vary by journal and are the responsibility of the authors.

Based on past experience, we expect that most research presented at the conference will be published within a few months of the conference.  But please be aware that journals reserve the right to do further review or even reject recommended manuscripts.

Journals which have agreed to work with us include:

  • Bioinformatics
  • Bioinformatics Advances
  • Journal of Bioinformatics and Computational Biology
  • BMC Bioinformatics
  • GigaScience
  • GigaByte

Bioinformatics and GigaScience are highly competitive so at most only a few manuscripts will be published in those journals.  The Journal of Bioinformatics and Computational Biology, and BMC Bioinformatics, are well established journals which have published many articles from GIW and ISCB-Asia in the past.  Bioinformatics Advances and GigaByte are new journals with strong organizational support.  We believe they have a bright future.

Submission site: https://easychair.org/my/conference?conf=giwiscbasia2022

Submission deadline: August 17, 2022

GIW XXXI/ISCB-Asia V will be held (in-person or virtually) in Tainan, Taiwan from Dec. 12 to 14, 2022. 

 
Learn More / Submit A Paper
Facebook
Twitter
Link
Website